PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Labor Augsburg MVZ GmbH, Augsburg, Germany.\', \'MVZ Labor Limbach, Heidelberg, Germany.\', \'Labor Berlin, Charité Vivantes Services GmbH, Berlin, Germany.\', \'University Children\'s Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John and the University Hospital, University of Regensburg, Germany.\', \'Institute for Laboratory Medicine, Microbiology and Hygiene, Barmherzige Brüder Hospital, Regensburg, Germany.\', \'Roche Diagnostics GmbH, Penzberg, Germany.\', \'Interregionale Blood Transfusion Swiss Red Cross, Bern, Switzerland; Institute for Infectious Diseases (IFIK), University of Bern, Bern, Switzerland. Electronic address: Christoph.Niederhauser@itransfusion.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-0934(21)00210-X10.1016/j.jviromet.2021.114271
?:doi
?:hasPublicationType
?:journal
  • Journal of virological methods
is ?:pmid of
?:pmid
?:pmid
  • 34461153
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.858
?:rankingScore_hIndex
  • 88
?:title
  • Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34461153>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34461153>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all